Sabby Management’s Immunomedics Inc IMMU Stock Holding History

Sabby Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-50,000	Closed	-$4.25M	–	167
2020 Q3	$4.25M	Buy	+50,000	New	+$2.53M	0.63%	28
2017 Q1	–	Sell	-50,000	Closed	-$253K	–	346
2016 Q4	$184K	Sell	50,000 -247,310	-83%	-$732K	0.01%	247
2016 Q3	$966K	Sell	297,310 -127,690	-30%	-$357K	0.04%	189
2016 Q2	$986K	Buy	+425,000	New	+$1.42M	0.05%	160
2016 Q1	–	Hold	0	–	–	–	3
2015 Q2	–	Sell	-137,751	Closed	-$528K	–	379
2015 Q1	$528K	Buy	+137,751	New	+$599K	0.02%	230

Sabby Management's IMMU Position: Q4 2020 in Review

Sabby Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 50,000 shares — an estimated $4.25M sold.

Sabby Management first reported a position in IMMU in Q1 2015 and held it in 5 quarters. The position peaked at $4.25M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Sabby Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Sabby Management sold 50,000 Immunomedics Inc shares in Q4 2020, an estimated $4.25M.
Sabby Management first reported a position in Immunomedics Inc in Q1 2015 and held it in 5 quarters.
Sabby Management's Immunomedics Inc position peaked at $4.25M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Sabby Management's 13F filing for Q4 2020, filed 16 Feb 2021.